EGFR and ERBB2 Exon 20 Insertion in Advanced Non-Small Cell Lung Cancer: Genomic Profiling and Clinicopathologic Features

被引:0
|
作者
Dundar, Bilge [1 ]
Sompallae, Ramakrishna [2 ]
Guseva, Natalya [1 ]
Bossler, Aaron [1 ]
Ma, Deqin [2 ]
机构
[1] Univ Iowa, Iowa City, IA USA
[2] Univ Iowa Hosp & Clin, Iowa City, IA 52242 USA
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
1199
引用
收藏
页码:1299 / 1301
页数:3
相关论文
共 50 条
  • [1] EGFR and ERBB2 Exon 20 Insertion in Advanced Non-Small Cell Lung Cancer: Genomic Profiling and Clinicopathologic Features
    Dundar, Bilge
    Sompallae, Ramakrishna
    Guseva, Natalya
    Bossler, Aaron
    Ma, Deqin
    [J]. MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 1299 - 1301
  • [2] EGFR and ERBB2 exon 20 insertion/duplication in advanced non-small cell lung cancer: genomic profiling and clinicopathologic features
    Sompallae, Ramakrishna R.
    Dundar, Bilge
    Guseva, Natalya V.
    Bossler, Aaron D.
    Ma, Deqin
    [J]. FRONTIERS IN ONCOLOGY, 2023, 13
  • [3] ERBB2 exon 20 insertions are rare in Brazilian non-small cell lung cancer
    Cavagna, Rodrigo de Oliveira
    Zaniolo, Beatriz Garbe
    de Paula, Flavia Escremim
    Berardinelli, Gustavo Noriz
    Santana, Iara
    Albino da Silva, Eduardo Caetano
    Dias, Josiane Mourao
    Jacinto, Alexandre Arthur
    Noleto da Nobrega Oliveira, Rachid Eduardo
    de Marchi, Pedro
    Leal, Leticia Ferro
    Reis, Rui Manuel
    [J]. THORACIC CANCER, 2022, 13 (23) : 3402 - 3407
  • [4] EGFR exon 20 insertion mutations in non-small cell lung cancer
    Wang, Fenfang
    Li, Chenghui
    Wu, Qihuan
    Lu, Hongyang
    [J]. TRANSLATIONAL CANCER RESEARCH, 2020, 9 (04) : 2982 - 2991
  • [5] Real-world frequency of non-small cell lung cancer with ERBB2 exon 20 insertion (Exon20ins) mutations by site of insertion.
    Yang, Li
    Huang, Tanxiao
    Qu, Yuan
    Wang, Qichen
    Teng, Jiaman
    Yang, Bo
    Chen, Shifu
    Kong, Feng-Ming Spring
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [6] Targeting EGFR exon 20 insertion mutations in non-small cell lung cancer
    Simon Vyse
    Paul H. Huang
    [J]. Signal Transduction and Targeted Therapy, 4
  • [7] Targeting EGFR exon 20 insertion mutations in non-small cell lung cancer
    Vyse, Simon
    Huang, Paul H.
    [J]. SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2019, 4 (1)
  • [8] The Co-Occurring Genomic Landscape of ERBB2 Exon 20 Insertion in Non-Small Cell Lung Cancer (NSCLC) and the Potential Indicator of Response to Afatinib
    Yuan, B.
    Zhao, J.
    Zhou, C.
    Wang, X.
    Zhu, B.
    Zhuo, M.
    Yi, C.
    Zhang, H.
    Dong, X.
    Feng, J.
    Yang, Y.
    Zhou, W.
    Chen, Z.
    Yang, S.
    Zhang, Y.
    Ai, X.
    Chen, K.
    Cui, X.
    Liu, D.
    Wu, W.
    Shi, C.
    Chang, L.
    Li, J.
    Chen, R.
    Yang, S.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S412 - S412
  • [9] Clinical Outcomes of EGFR Exon 20 Insertion Mutations in Advanced Non-small Cell Lung Cancer in Korea
    Byeon, Seonggyu
    Kim, Youjin
    Lim, Sung Won
    Cho, Jang Ho
    Park, Sehoon
    Lee, Jiyun
    Sun, Jong-Mu
    Choi, Yoon-La
    Lee, Se-Hoon
    Ahn, Jin Seok
    Park, Keunchil
    Ahn, Myung-Ju
    [J]. CANCER RESEARCH AND TREATMENT, 2019, 51 (02): : 623 - 631
  • [10] Advanced Non Small Cell Lung Cancer With EGFR Exon 20 Insertion Gene Mutation
    Lam, N. S.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S510 - S510